In a study using preclinical AD individuals that are cognitively healthy but have abnormal amyloid level, it was found that APOE4 directly increased tau PET burden in medial temporal lobe (entorhinal cortex and amygdala) beyond effects attributable to amyloid accumulation (Young et al., 2023). The gene discussed is MAPT; the disease is Alzheimer disease.